EQS-AFR: PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

23.04.25 14:30 Uhr

Werte in diesem Artikel
Aktien

23,60 EUR 0,00 EUR 0,00%

EQS Preliminary announcement financial reports: PharmaSGP Holding SE / Preliminary announcement on the disclosure of financial statements
PharmaSGP Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

23.04.2025 / 14:30 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Wer­bung


PharmaSGP Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: April 30, 2025
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 30, 2025
Address: https://ir.pharmasgp.com/en/#FinancialReports

Report Type: Annual financial report of the group

Language: German
Date of disclosure: April 30, 2025
Address: https://ir.pharmasgp.com/#Finanzberichte

Language: English
Date of disclosure: April 30, 2025
Address: https://ir.pharmasgp.com/en/#FinancialReports


23.04.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: PharmaSGP Holding SE
Lochhamer Schlag 1
82166 Gräfelfing
Germany
Internet: https://pharmasgp.com

 
End of News EQS News Service

Wer­bung

2122398  23.04.2025 CET/CEST

Ausgewählte Hebelprodukte auf PharmaSGP

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf PharmaSGP

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu PharmaSGP

Wer­bung